Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases

Applied Regression Analysis and Other Multivariable Methods

1989 • 8,685 citations

Cancer: Principles and Practice of Oncology.

1991 • 8,402 citations

The palliation of symptomatic osseous metastases final results of the study by the radiation therapy oncology group

1982 • 813 citations

Cancer: Principles and Practice of Oncology

1982 • 513 citations

The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer.

1962 • 441 citations

"S," absorbed dose per unit cumulated activity for selected radionuclides and organs

1975 • 279 citations

Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors: Final radiation therapy oncology group report

1986 • 221 citations

In vivo quantitation of lesion radioactivity using external counting methods

1976 • 186 citations

The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine

1986 • 166 citations

Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.

1991 • 162 citations

Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer.

1990 • 146 citations

Re-186(Sn) HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies.

1988 • 129 citations

Comparison of the chemical and biological properties of trans-[Tc(DMPE)2Cl2]+ and trans-[Re(DMPE)2Cl2]+, where DMPE = 1,2-bis(dimethylphosphino)ethane. Single-crystal structural analysis of trans-[Re(DMPE)2Cl2]PF6

1985 • 76 citations

Separation of technetium hydroxyethylidene diphosphonate complexes by anion-exchange high performance liquid chromatography

1980 • 63 citations

Preparation of rhenium-186 labelled EHDP and its possible use in the treatment of osseous neoplasms

1979 • 59 citations

In vivo distributions of some component fractions of Tc(NaBH4)-HEDP mixtures separated by anion exchange high performance liquid chromatography

1982 • 52 citations

Effect of pH on the formation of Tc(NaBH4)-MDP radiopharmaceutical analogues

1983 • 44 citations

Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.

1989 • 31 citations

Safety and Efficacy of Repeated Sequential Administrations of Re-186(Sn)HEDP as Palliative Therapy for Painful Skeletal Metastases

1992 • 28 citations

The biological distributions of some technetium-MDP components isolated by anion exchange high performance liquid chromatography

1983 • 27 citations

Preparation of 186Re-Perrhenate for nuclear medical purposes

1982 • 27 citations

The effect of formulation conditions on the distribution of 99mTc(NaBH4)-HEDP components separated by anion exchange HPLC

1986 • 14 citations

186Re-HEDP: A Potential Therapeutic Bone Agent

1984 • 7 citations

HPLC separated fractions of 99mTc(NaBH4)-HEDP as myocardial infarct imaging agents

1986 • 4 citations